| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $251K | -99.3% |
| R&D Expense | $50.3M | +0.2% |
| SG&A Expense | $17.2M | +23.7% |
| Operating Income | -$67.3M | -119.4% |
| Pre-tax Income | -$65.4M | -128.2% |
| Income Tax | $0 | -100.0% |
| Net Income | -$65.4M | -127.6% |
| EPS (Basic) | -$5.81 | +83.8% |
| EPS (Diluted) | -$5.81 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.2M | -24.8% |
| Short-term Investments | $145.2M | +518.7% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $188.6M | +136.3% |
| Total Assets | $209.6M | +99.4% |
| Current Liabilities | $12.3M | +0.2% |
| Total Liabilities | $22.9M | -54.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$55.0M | -16.0% |
| Capital Expenditures | $642K | -80.3% |
| Investing Cash Flow | -$120.5M | -363.8% |
| Financing Cash Flow | $162.2M | +565.1% |
| Free Cash Flow | -$55.7M | -9.8% |
| +83.8% |
| Stockholders' Equity |
| $186.6M |
| +215.2% |